Scarica l'app Stockscreener
3.43
1.44%
-0.05
Dopo l'orario di chiusura:
3.47
0.04
+1.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.48
Aprire:
$3.51
Volume 24 ore:
237.42K
Relative Volume:
1.29
Capitalizzazione di mercato:
$136.52M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
31.18
EPS:
0.11
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
+17.87%
1M Prestazione:
+27.99%
6M Prestazione:
+58.06%
1 anno Prestazione:
+44.12%
Intervallo 1D:
$3.3101
$3.54
Intervallo di 1 settimana:
$2.86
$3.54
Portata 52W:
$1.82
$3.54
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Nome
Oramed Pharmaceuticals Inc
Settore
Industria
Telefono
646-844-1164
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Confronta ORMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
3.43 | 138.51M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-09 | Iniziato | National Securities | Buy |
| 2020-12-03 | Iniziato | Alliance Global Partners | Buy |
| 2020-03-11 | Iniziato | Aegis Capital | Buy |
| 2019-09-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-12-11 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Reiterato | FBR Capital | Outperform |
| 2015-12-01 | Reiterato | H.C. Wainwright | Buy |
| 2015-11-19 | Iniziato | FBR Capital | Outperform |
| 2015-04-13 | Ripresa | MLV & Co | Buy |
| 2014-01-30 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Iniziato | MLV & Co | Buy |
| 2013-12-03 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
Is Oramed Pharmaceuticals Inc. stock a buy in volatile markets2025 Retail Activity & Daily Volume Surge Signals - ulpravda.ru
Will Oramed Pharmaceuticals Inc. stock outperform value stocks2025 Key Lessons & Intraday High Probability Alerts - ulpravda.ru
Oramed inks deal with Medicox for oral insulin in South Korea - The Pharma Letter
MSN Money - MSN
Oramed Pharmaceuticals Inc. Approves Cash Dividend Payable on January 26, 2026 - MarketScreener
Oramed stock rises after receiving $18 million payment from Scilex By Investing.com - Investing.com South Africa
Oramed receives $18 million payment from Scilex, declares dividend By Investing.com - Investing.com Nigeria
Oramed Pharm Announces Dividend After Scilex Payment Gain - TipRanks
Oramed receives $18 million payment from Scilex, declares dividend - Investing.com
Oramed Pharmaceuticals Inc Receives $18 Million Payment and Approves Dividend - TradingView — Track All Markets
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments - PR Newswire
What analysts say about Oramed Pharmaceuticals Inc stockLow Beta Stocks & Breakthrough Profit Margins - earlytimes.in
Oramed Pharmaceuticals director Leonard Sank to resign after 18 years By Investing.com - Investing.com Nigeria
Oramed Pharmaceuticals director Leonard Sank to resign after 18 years - Investing.com
Oramed Pharm Announces Long-Tenured Director’s Upcoming Resignation - TipRanks
Oramed Pharmaceuticals completes $28.5 million warrant repurchase by Scilex - Investing.com Nigeria
Oramed Pharm Completes Warrant Sale, Boosting Liquidity - TipRanks
Oramed Pharmaceuticals Completes Warrant Repurchase with Scilex - TradingView — Track All Markets
Scilex Holding completes $27 million repurchase of warrants from Oramed By Investing.com - Investing.com South Africa
Scilex Holding completes $27 million repurchase of warrants from Oramed - Investing.com India
Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback - Seeking Alpha
Analyst Downgrade: Will Oramed Pharmaceuticals Inc stock outperform value stocksRate Hike & Daily Market Momentum Tracking - moha.gov.vn
Total debt per share of Oramed Pharmaceuticals Incorporated – TRADEGATE:OJU1 - TradingView — Track All Markets
Is Oramed Pharmaceuticals Inc. (OJU1) stock suitable for passive index fundsQuarterly Profit Review & Reliable Volume Spike Alerts - Улправда
Aug Swings: Will Oramed Pharmaceuticals Inc stock outperform value stocksWeekly Stock Analysis & Expert Verified Stock Movement Alerts - moha.gov.vn
Why Oramed Pharmaceuticals Inc. stock could outperform in 2025Recession Risk & Daily Technical Forecast Reports - Улправда
Oramed Pharmaceuticals (FRA:OJU1) EV-to-OCF : 1.41 (As of Dec. 19, 2025) - GuruFocus
Will Oramed Pharmaceuticals Inc. stock maintain growth storyQuarterly Trade Review & Target Return Focused Picks - DonanımHaber
Can Oramed Pharmaceuticals Inc. stock withstand economic slowdownProduct Launch & Daily Stock Trend Watchlist - DonanımHaber
Can Oramed Pharmaceuticals Inc. (OJU1) stock double in coming yearsQuarterly Portfolio Summary & Verified High Yield Trade Plans - DonanımHaber
Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Oramed Pharmaceuticals Earnings Notes - Trefis
How strong dollar benefits Oramed Pharmaceuticals Inc. (OJU1) stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - Newser
Why Oramed Pharmaceuticals Inc. stock appeals to analystsJobs Report & Free AI Powered Buy and Sell Recommendations - Newser
Will Oramed Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - Newser
Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthRate Hike & Community Verified Trade Signals - Newser
How Oramed Pharmaceuticals Inc. (OJU1) stock correlates with oil markets2025 Short Interest & Stock Market Timing Techniques - Newser
How Oramed Pharmaceuticals Inc. (OJU1) stock valuation compares with sectorJuly 2025 Final Week & Weekly Setup with High ROI Potential - Newser
Is Oramed Pharmaceuticals Inc. (OJU1) stock a buy on weakness2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Is Oramed Pharmaceuticals Inc a good long term investmentSector Performance Review & High Yield Trading Growth - earlytimes.in
ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted - Yahoo Finance
Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):